Terrence Blaschke

Terrence F. Blaschke, MD, is a Medicine and Molecular Pharmacology (Emeritus) Professor at Stanford University, Adjunct Professor of Bioengineering and Therapeutic Sciences at UCSF and Adjunct Professor of Medicine at Indiana University. Dr. Blaschke received his medical degree from Columbia University and did his residency training in Internal Medicine at UCLA. Following fellowship training in Clinical Pharmacology at the University of California, San Francisco, he joined the faculty at Stanford University School of Medicine in 1974.

Dr. Blaschke is a past president of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). He is the recipient of the Rawls-Palmer award, the Henry W Elliott award and the Oscar B. Hunter award from ASCPT. He has been a consultant and past Chair of the Generic Drugs Advisory Committee of the US FDA and a member of the Nonprescription Drugs Advisory Committee. He chaired the Drug Utilization Review Panel of The U.S. Pharmacopeial Convention (USP) from 1995-2000. He served on the Board of Directors of Therapeutic Discovery Corporation of Palo Alto, Crescendo Pharmaceuticals, in Mountain View, California and is now a member of the board of directors of DURECT Corporation in Cupertino, California.

From November 2012 through 2015, Dr. Blaschke was a Senior Program Officer/Senior Advisor at the Bill and Melinda Gates Foundation in Seattle, WA, and is now a consultant to the BMGF. Dr. Blaschke is and has been a consultant to a number of pharmaceutical firms